NCT02537795 Psychiatric Neurosurgery (PNS) for Obsessive Compulsive Disorder (OCD): A Qualitative Analysis of Patient and Family Member Experiences
| NCT ID | NCT02537795 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Obsessive-Compulsive Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2015-08 |
| Primary Completion | 2025-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2015-08 with a primary completion date of 2025-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study the investigators will use semi-structured interviews to qualitatively analyse patient and family member experiences with either deep brain stimulation or other forms of psychiatric neurosurgery.
Eligibility Criteria
Inclusion Criteria: * (family member of) patient who has previously been treated with deep brain stimulation or anterior capsulotomy Exclusion Criteria: * none
Contact & Investigator
Chris Bervoets, MD, PhD
PRINCIPAL INVESTIGATOR
UPC KU Leuven
Frequently Asked Questions
Who can join the NCT02537795 clinical trial?
This trial is open to participants of all sexes, studying Obsessive-Compulsive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02537795 currently recruiting?
Yes, NCT02537795 is actively recruiting participants. Contact the research team at simon.raymaekers@uzleuven.be for enrollment information.
Where is the NCT02537795 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT02537795 clinical trial?
NCT02537795 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Chris Bervoets, MD, PhD at UPC KU Leuven. The trial plans to enroll 40 participants.